Mycoplasma pneumoniae (Mp) is one of the leading causes of community-acquired pneumonia and can cause a number of extrapulmonary manifestations in the absence of pneumonia. In this regard, primary care physicians should know how to suspect, diagnose, and manage patients with Mp infection. This review gives a general overview of the basic clinical aspects of Mp infection with special reference to pneumonia, which will help further understanding of the disease.
| INTRODUCTION
Mycoplasma and ureaplasma species are known to occur in humans.
The term "mycoplasma" (Greek; "mykes"=fungus and "plasma"=formed) 
| HISTORY OF ISOLATION OF MYCOPLASMA PNEUMONIAE
In 1938, Reimann reported seven patients with an unusual form of tracheobronchopneumonia and severe constitutional symptoms. 2, 3 He believed the clinical picture of this disease differed from that of diseases caused by influenza viruses or known bacteria and "primary atypical pneumonia" was suspected. In the early 1940s, Eaton et al. [4] [5] [6] identified an agent that was the principal cause of primary atypical pneumonia using cotton rats, hamsters, and chick embryos, which was referred to as the "Eaton agent." 
| MP PNEUMONIA
The clinical findings of Mp pneumonia are diverse 16 (Table 1) 19 Therefore, primary care physicians should be aware of these six factors that help discriminate Mp pneumonia from other causes of CAP using the JRS "diagnostic tests" 10 ( Table 4 ).
| MACROLIDE-RESISTANT MP PNEUMONIA
Macrolide Life-threatening illness is extremely rare, and there are no apparent risk factors for fulminant Mp pneumonia. 24 
| EXTRAPULMONARY MANIFESTATIONS
Our preliminary data showed the typical diverse symptoms of Mp pneumonia ( Figure 3 ). About 70% of patients experienced fever and cough (typically dry cough). Interestingly, 7% of patients had dermatologic involvement. Importantly, extrapulmonary manifestations due to Mp infection sometimes occur in the absence of Mp pneumonia or even in the absence of respiratory symptoms. 25 As seen in 
| PATHOGENESIS OF MP PNEUMONIA
The severity of Mp respiratory disease appears to be related to the degree to which the host immune response reacts to the infection.
This was confirmed by our "mice models" for Mp pneumonia sensitized with various conditions. 14,27-29 Mp attaches to bronchial epithe- 
33
Other factors are well known for their harmful effects via oxidative stress.
| ASSOCIATION OF MYCOPLASMA PNEUMONIAE WITH BRONCHIAL ASTHMA
Several reports have described that Mp infection may be associated with pediatric asthma exacerbation 34 more often than in adults.
35,36
Yano et al. 37 reported that mycoplasmal respiratory infections on the airway involved a complex interplay of airway inflammation via Asahi Kasei Pharma Corp, Japan) 58, 59 using throat swabs are also commercially available.
| DIAGNOSTIC METHODS
If either CF titers are higher than 1:64 or PA titers are higher than 1:320, a diagnosis of Mp infection can be made. In previous reports, the results of the IC Mycoplasma test were not concordant with that of the PA test, especially in adults, 60 which requires a fourfold rise in titers for a diagnosis to be made in adults (Table 3) .
Although a few laboratories can use PCR-based diagnostics, the sensitivity and specificity for Mp infection are 40.7%-66.7% and 88.8%-98.5%, respectively, with the serological diagnosis used as the reference standard. 14, 61 The LAMP assay, a novel nucleic acid amplification method for the rapid detection of Mp by throat swab, was recently developed and became commercially available in 2010 in Japan with the same sensitivity and specificity for detecting Mp as PCR. 62 When the results of serological tests were considered as the standard, the sensitivity, specificity, and positive and negative predictive values of the LAMP assay were 94.8%, 91.9%, 91.1%, and 95.2%, respectively. 63 The median duration of pharyngeal carriage, as measured by the LAMP assay, was 9.5 days. When the LAMP assay is compared to a validated real-time PCR test, the sensitivity of the LAMP assay was 88.5% tested on extracted nucleic acid and 82.1% evaluated on unextracted clinical specimens. 64 In this regard, the LAMP assay will enable rapid (within a few hours), low-cost detection of Mp infection.
Optimal sample site varies in terms of pathogens or age. Sputum may be superior to nasopharyngeal swabs or oropharyngeal swabs in detection of Mp by nucleic acid amplification method from adults patients. (Table 4) . If four or more of the proposed factors are present, Mp pneumonia can be easily discriminated from the other pathogens with high sensitivity (88.7%) and moderate specificity (77.5%). 66 
| RADIOLOGICAL FEATURES
In our unpublished data, a prominent feature of chest X-ray, both in children and adults with Mp pneumonia, was consolidation followed by ground glass opacities, which was predominantly seen in the middle to lower lung fields. Figure 6D ) are prominent features of Mp pneumonia. 18, 67, 68 In differentiating from Streptococcus pneumoniae pneumonia, the presence of centrilobular nodules indicates Mp pneumonia. 
T A B L E 3 Diagnostic methods for Mp pneumonia
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